GlassScriptPhysician profile
Pramod A Reddy
NPI 1063417996
$4,705.40
in general payments reported to CMS, 2019-2025
20 companies · $749 in 2025
The $749 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $636 · 2020: $243 · 2021: $329 · 2022: $666 · 2023: $1,079 · 2024: $1,004 · 2025: $749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,719 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,719.13 |
| Education | $112.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,117.57 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,030.41 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $529.48 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $271.07 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $240.60 | 2019-2025 | Brilinta, Farxiga |
| Amgen INC. | $236.88 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $232.91 | 2019-2025 | Lifevest |
| Irhythm Technologies, INC. | $177.44 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Abbott Laboratories | $159.29 | 2019-2024 | Cardiomems, Assurity, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $129.71 | 2021-2025 | Bodyguardian, Lux-Dx Insertable Cardiac Monitor, Cds - Mct/Cem Monitoring |
| E.R. Squibb & Sons, L.L.C. | $126.78 | 2022-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.00 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $106.01 | 2023-2024 | Inpefa |
| Novo Nordisk INC | $76.71 | 2025 | Wegovy |
| Sanofi-Aventis U.S. LLC | $58.68 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $21.83 | 2023 | Uptravi |
| Medtronic Vascular, INC. | $21.01 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $19.49 | 2024 | Arcalyst |
| Osprey Medical INC | $18.00 | 2019 | |
| Philips North America LLC | $16.53 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pramod Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.